This speculation is in line with our observations in this work: convergent TCRs are enriched for antigen-experienced receptors, and these T cells exhibited a neoantigen-specific, cytotoxic CD8+ phenotype in the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.